TrialPancreas2025
Phase II Randomized Controlled Trial to Evaluate the Supportive Effect of Koujin (TJ-3020) Powder in Gemcitabine and Nab-Paclitaxel-Treated Unresectable or Recurrent Pancreatic Cancer.
Tomohisa Otsu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it